Latest News
Northern Sydney leading the way with arthritis research and clinical care
Posted on: 22 July, 2019
The latest exciting research into musculoskeletal disease has been unveiled during the inaugural Northern Lights showcase.
Close to 200 people attended the jam packed event in the Kolling auditorium, including clinicians, researchers and many people living with arthritic pain.
RNSH Head of Rheumatology Professor Lyn March addressed the event, detailing the devastating cost of the disease to indivi.....
Read more
Category: New Treatment
Recognition for the Kolling Director
Posted on: 12 June, 2019
The Kolling’s Director of Research Professor Carolyn Sue has been awarded a Member of the Order of Australia (AM) in this year’s Queen’s Birthday Honours for her significant service to medicine, particularly mitochondrial disease.
Carolyn is a highly accomplished neurologist and is internationally regarded for her work in both Parkinson’s and mitochondrial disease.
Recently appointed to the Directo.....
Read more
New world leading technology to guide future bowel cancer treatment
Posted on: 12 June, 2019
Research capabilities within the Kolling Institute have been significantly broadened with new technology to assist the examination of bowel cancer.
Representatives from Sydney University, the Kolling and Bowel Cancer Australia attended the official opening of the mass spectrometry core lab – the first of its type on a hospital campus and one of the best analytical facilities in the world.
Professo.....
Read more
Category: World-leading technology, New Treatment
